April 22, 2026

What is a Perception Audit and What are the Benefits to a Public Biotech of Undertaking One?

A perception audit is a structured, independent assessment of how investors, analysts, and other market participants view a biotech, its strategy, leadership, science, communication, and prospects.

Typically conducted by a neutral third party (like your IR partner), it consists of confidential interviews or surveys with a company’s key stakeholders, usually:

• Current shareholders
• Former investors
• Prospective investors
• Covering analysts
• Non-covering analysts who cover peers (where relevant)

While their feedback is collated, analyzed, and shared with management, all interviewee responses remain anonymous.

The objective of a perception audit is to understand how a company is genuinely perceived compared to the platitudes and niceties you might receive face to face.

How a perception audit works

Although each audit – taking roughly 6 weeks – is customized to each biotech’s needs, most follow a similar process:

Weeks 1-2:

• Define your objectives. What do you want to learn? For example, is The Street aligned with your clinical development strategy? Are investors comfortable with your financing plan? Do they see your pipeline as differentiated or risky?
• Engage an independent party. Investors and analysts are far more candid when speaking with an unbiased third party, especially when they are guaranteed anonymity.
• Select your targets: The organizer of your perception audit should target a diverse mix of stakeholders. Altogether these names will likely number 80-100 individuals, though probably only around 20 will participate.
• Develop the questionnaire. Questionnaires usually consist of no more than 10 long-form (open-ended) questions and 10 short-form or binary questions, making perhaps 20 in total. These should be interspersed with one another to enhance the flow of interviews.

Weeks 3-4 :

• Conduct both the outreach and interviews. Participants obviously self-select. Typically, all your covering analysts will take part and maybe 10-15% of your investors. Interviews can take place by phone or virtually via Zoom/Teams (the latter option enabling you to use AI to create a transcript in record time). Interviews are marketed as being around 15 minutes long but, in practice, are more likely to take around 30 minutes each.

Weeks 5-6:

• Analyze the results. Responses are aggregated and can be compared to previous perception audits and internal expectations.
• Report and act. Findings are then shared with management, potentially the company’s Board, and any internal IR team – along with clear recommendations on  changes to messaging, disclosure, and future engagement, to better align internal and external views of the company.

Benefits of conducting a perception audit

1. Understand how the market actually views your company

Management teams are inherently too close to their own story, and the feedback they receive in regular investor interactions is often softened by access dynamics and future financing considerations. A perception audit cuts through that noise and provides an unvarnished view of how investors truly classify your company, your lead assets, and your stage of development – often revealing gaps between management’s self-assessment and market reality.

2. Pressure-test your messaging

Biotech messaging must translate complex science, regulatory strategy, and capital plans into something investors can quickly absorb and underwrite. A perception audit identifies which parts of that message are resonating, and where confusion persists – frequently around development risk, timelines, or cash runway, all of which management may have assumed are well understood.

3. Prepare more effectively for Investor Days and inflection points

Investor Days and major announcements are rare opportunities to reset expectations. A pre-event perception audit functions as a rehearsal with The Street, highlighting misconceptions to address, topics requiring greater clarity, and areas where management credibility needs to be reinforced.

4. Build credibility with investors and the board

Running a perception audit signals transparency, discipline, and self-awareness. Investors and analysts value being asked for candid input, and the process often strengthens relationships rather than straining them. For boards, the results provide an independent check on how strategy and execution are being received externally.

5. Informing strategy – not just investor relations

Perception audits routinely cover strategic issues that go beyond IR. Persistent investor skepticism around a program, capital strategy, or positioning may warrant internal reassessment or additional validation. The feedback comes from experienced market participants and should be weighed seriously alongside management’s internal perspective.

When to conduct a perception audit

Perception audits take up a great deal of time – and use up stakeholder goodwill – so they should be used sparingly.  Times when they might be appropriate include:

• Ahead of an Investor Day or major scientific presentation
• Following a strategic pivot or leadership change
• After a key data readout
• During periods of (relative) stock underperformance

While there is an argument for regular perception audits to identify trends – and some in the IR community would even suggest conducting them annually – I would instead argue that they should be used more strategically, and therefore less frequently. Biotech stories just don’t change that quickly and clinical trials can take years to complete. Forcing a regular cadence of perception audits that ignores the long-term nature of clinical development is counterproductive.

Once you know, act

Critically, perception audits only deliver value if their findings are acted upon. Common actionable items post-audit include:

• Updating investor decks and company FAQs to clarify misconceptions
• Coaching management on key messaging consistency
• Adjusting disclosure practices for greater transparency
• Aligning your Investor Day agenda with the issues investors care most about
• Actual changes to the company’s strategic development plan

Progress before pride

Perception audits are not about flattering management; they are about optimizing a biotech’s public perception. Done well, they can – over time – lead to a higher share price, better decision making by management, and greater access to capital.

Sometimes management will receive feedback they do not like. They should be prepared for this. Sugarcoating – or worse, misrepresenting the findings of a perception audit – defeats the purpose of undertaking one in the first place.